Overview of Glp 1 Medications Infographic
GLP-1 medications are effective options for weight loss and diabetes. What you need to know is covered in this article and infographic
A GLP-1 Drugs Infographic Download the infographic to see key report statistics about how organizations are viewing GLP-1 coverage for obesity and more.
Key Details About Glp 1 Medications Infographic
This infographic shows key figures on usage/opinion about GLP-1 medication to treat obesity in the U.S.
What are GLP-1 agonists? GLP-1 medications are used to help with weight loss and Type 2 diabetes. They work by acting like a natural hormone in the body called GLP-1 . This hormone helps control blood sugar and hunger. These medications help you feel full for longer, so you eat less and lose weight. They also help lower blood sugar by telling your body to release insulin when needed.
All FDA
A complete guide to all FDA-approved GLP-1 medications in 2026, including Wegovy, Zepbound, Foundayo, Ozempic, Mounjaro, Saxenda, Rybelsus, and Victoza. Compare indications, forms, pricing, and which is right for you.
The GLP-1 drugs now used for treatment of obesity began as type 2 diabetes drugs. Given the high demand for GLP-1s and rapidly shifting environment with respect to these drugs, learning payers' perspectives is critical.
PDF For Healthcare Professionals
According to the guidance28 and reference SmPC's for each medication in this class, the individual risk factors listed below would indicate non-eligibility for the GLP-1/GIP class of medications .
In this McKinsey Explainer, we look into what are GLP-1 medications and explore how they work, side effects, and more.
Key Details About Glp 1 Medications Infographic
GLP-1 agonists (known as GLP-1 receptor agonists to those who study them) are drugs designed to mimic the GLP-1 that your body naturally produces, giving you an extra boost of this "I'm full" hormone. The drugs bind to the same GLP-1 receptor in the body that natural GLP-1 binds to, and therefore have the same effects.
GLP-1 drugs such as Ozempic, Trulicity, and Mounjaro all lower blood sugar, but they differ in FDA indication, average weight-loss, dosing schedule, and out-of-pocket cost. Wegovy® and Zepbound™ are higher-dose versions cleared exclusively for chronic weight management, while Victoza® and Byetta® have shorter daily dosing windows.